XML 108 R91.htm IDEA: XBRL DOCUMENT v3.24.0.1
Loss Per Common Share - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Earnings Per Share [Abstract]                      
Loss from continuing operations                 $ (113,040) $ (18,701) $ (30,284)
Loss from discontinued operations, net of tax [1]                 0 (463) (7,317)
Loss before preferred dividends and accretion of Series A Preferred Stock $ (33,411) $ (25,324) $ (34,323) $ (19,982)         (113,040) (19,164) (37,601)
Dividends and accretion of Series A Preferred Stock (7,984) (7,872) (7,088) (6,276)         (29,220) 0 0
Net (loss) attributable to common shareholders of Evolent Health, Inc. - Basic (41,395) (33,196) (41,411) (26,258) $ (11,349) $ 2,123 $ (4,588) $ (5,350) (142,260) (19,164) (37,601)
Net (loss) attributable to common shareholders of Evolent Health, Inc., Inc. - Diluted $ (41,395) $ (33,196) $ (41,411) $ (26,258) $ (11,349) $ 2,123 $ (4,588) $ (5,350) $ (142,260) $ (19,164) $ (37,601)
Weighted-average common shares outstanding - basic (in shares)                 111,251 93,699 86,067
Weighted-average common shares outstanding - diluted (in shares)                 111,251 93,699 86,067
Basic and diluted:                      
Continuing operations, basic (in dollars per share)                 $ (1.28) $ (0.20) $ (0.35)
Continuing operations, diluted (in dollars per share)                 (1.28) (0.20) (0.35)
Discontinued operations basic (in dollars per share)                 0 0 (0.09)
Discontinued operations diluted (in dollars per share)                 0 0 (0.09)
Basic loss per share attributable to common shareholders of Evolent Health, Inc. (in dollars per share) $ (0.36) $ (0.30) $ (0.37) $ (0.24) $ (0.11) $ 0.02 $ (0.05) $ (0.06) (1.28) (0.20) (0.44)
Diluted loss per share attributable to common shareholders of Evolent Health, Inc. (in dollars per share) $ (0.36) $ (0.30) $ (0.37) $ (0.24) $ (0.11) $ 0.02 $ (0.05) $ (0.06) $ (1.28) $ (0.20) $ (0.44)
[1] Includes $0.5 million and $6.8 million loss on disposal of discontinued operations for the years ended December 31, 2022 and 2021, respectively